FDA Recall United States Ongoing Historical recordClass II
BAPS Shayona
- Product
- BAPS SHAYONA Sangam Katri Rose and nut fudge Net Wt: 12 Oz 4…
- Published
- December 13, 2023
- Distribution
- Product was shipped to the following sta…
Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA, WHO, and other public sources. It is an independent information service, not a medical provider, and not a substitute for professional medical advice or your local public health department's own guidance.
Please review the following before continuing:
Policy version 2026-07-21, effective July 21, 2026.
United States
OngoingClass II
During an FDA inspection the firm was notified that some of their products contains undeclared soy.
| Product description | UPC | Quantity | Lot / code information |
|---|---|---|---|
| BAPS SHAYONA Plain Penda Ricotta fudge discs flavored with rose water Net Wt: 12 Oz 460 Rockbridge Rd NW Lilburn, GA 30047 UPC 53152 Contains: Milk, Nut | Not published in this source record | 723 units | A06G2723 Best By 09/25/2023, A12G1323 Best By 9/11/2023, A06G0523 Best By 9/3/2023, A05F1423 Best By 8/13/2023, A04F0823 Best By 8/7/2023, A12E1723 Best By 7/16/2023 |
This recall shares FDA event ID 92774 with 9 other product entries in Public Health Trace.
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
Responsible company: BAPS Shayona
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
FDA Recall United States Ongoing Historical recordClass II
A map highlighting the states named in the source's distribution description.
Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.
| State | Distributed |
|---|---|
| Alabama | 1 |
| Florida | 1 |
| Georgia | 1 |
| North Carolina | 1 |
| South Carolina | 1 |
| Tennessee | 1 |
States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.
View FDA enforcement record -- the specific openFDA record this summary was built from.
No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.
FDA Enforcement Reports -- FDA's general, official recall and enforcement information.
View raw source data -- the machine-readable record this page's information was built from.
Retrieved by Public Health Trace:
A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.
According to FDA, this recall's status is "Ongoing." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.
Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.
The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.
This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.